Beta Bionics (BBNX) CMO Russell Steven Jon Sells 4,221 Shares

What Happened

• Russell Steven Jon, Chief Medical Officer of Beta Bionics (BBNX), reported a sale of 4,221 shares on 2026-09-02. The reported proceeds were $80,676 (sale price reported as $19.11 per share).
• The Form 4 lists the transaction as a sale (S); the filing indicates the shares were sold to cover tax withholding obligations tied to the vesting of restricted stock units (RSUs). This is a routine tax-withholding sale rather than a directional investment purchase.

Key Details

• Transaction date: 2026-09-02; Form filed: 2026-09-03 (appears timely).
• Reported sale quantity and value: 4,221 shares sold for total proceeds of $80,676; reported sale price shown as $19.11.
• Weighted average sale price and range (footnote): weighted avg $19.1131; price range $18.89–$19.545. The company can provide a per-price breakdown on request (per footnote).
• Reason for sale (footnote): shares sold to cover tax withholding on RSU vesting.
• Shares owned after transaction: not disclosed in this filing.

Context

• Tax-withholding sales on vesting of RSUs are common and typically procedural; they do not necessarily indicate the insider’s view of the company’s prospects.
• The filing does not show an option exercise or a strategic open-market purchase — it reports a sale tied to compensation tax obligations.